SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending due to its merger approval with HCYC, triggering a massive after-hours surge as traders speculate on a potential short squeeze, fueled by its low float. The community is drawing comparisons to similar low-float plays like $SMX and identifying potential sympathy plays, while also highlighting the risks associated with such volatile movements. ATMC's transition from a SPAC to an operating company post-merger is generating excitement and driving significant trading volume.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to news of a joint venture to build a rare earth plant in Romania, securing a supply chain for the EU. The community is discussing the significance of this deal, particularly how it de-risks the company and positions it to challenge China's dominance in rare earth processing. Many believe this could lead to a significant re-evaluation of the stock, especially with a BFS report potentially on the horizon.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as discussions revolve around the potential impact of recent FDA news related to AI-assisted tools in MASH clinical trials, specifically regarding biopsy analysis and trial efficiency. The community is actively speculating on upcoming catalysts, including 48-week data and a potential FDA meeting, with some expressing optimism about accelerated approval pathways and buyout possibilities, while others urge caution.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a massive intraday price surge, leading to multiple trading halts and high volatility; the community is actively discussing dip-buying opportunities and potential after-hours momentum. Some traders are attributing the unusual activity to a low float combined with interest in Chinese stocks, while others speculate about an impending short squeeze. Chatter suggests the stock may be confused with a private AI company, while the underlying business is in caviar.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp ($ATMV) is trending due to speculation surrounding its merger agreement, drawing comparisons to other high-flying SPACs. The stock's low float and potential short squeeze are key discussion points, with some traders eyeing a potential run similar to $ATMC. Community chatter suggests significant volatility and potential for substantial gains, while others caution about potential risks associated with low-float stocks.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to bullish coverage initiated by JPMorgan, with a price target significantly higher than the current trading price, sparking significant community discussion and a pre-market rally. Traders are actively discussing the small float and potential for a continued run, while also considering the implications of past offerings. The community is weighing the analyst upgrade against the backdrop of the company's financials and pipeline.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending following positive Phase 2 data for its drug Burixafor in treating multiple myeloma, with traders noting its small float and potential for a short squeeze. The stock's surge has captured the biotech market's attention, as evidenced by the buzz surrounding its stem-cell mobilization results. Community members are actively discussing entry points, possible short positions, and potential price targets.

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. ($CETX) is trending due to high volatility and speculation of a potential short squeeze, with community members pointing to its low float and significant trading volume. Some traders discuss recent news and potential acquisitions as bullish signals, while others express concern about dilution and the CEO's past actions. The stock experienced a large intraday swing, leading to heightened chatter and trading activity.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the completion of key equipment installation for its Eagle Line, a pilot production line for solid-state batteries, with an inauguration event planned for February 2026. The community is focused on whether this milestone will trigger OEM announcements, milestone payments, or further customer contracts. Broader discussions involve the company's progress toward commercialization and its potential position in the EV battery market.

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Moleculin Biotech Inc

Moleculin Biotech ($MBRX) is trending as investors digest the news of recent enrollment progress in its Phase 3 AML treatment trial, alongside a new research agreement for brain tumor treatment. While some express concerns about potential dilution, others see the completion of treatment for patients in the pivotal MIRACLE trial as a positive sign, anticipating news in Q1 2026. The community highlights the potential for a short squeeze due to high short interest and a relatively small float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
